Clinical Trials Browser

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT07410403 2026-02-13

AI

Enrolling by invitation

10 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02473757 2025-12-01

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Enrolling by invitation

1,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Hematologic Neoplasms

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

Phase 1/2 Enrolling by invitation

21 enrolled

Plasma cell

Multiple Myeloma

NCT03628612 2025-08-07

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Phase 2 Enrolling by invitation

500 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell

NCT07103863 2025-08-05

AL-CA

Enrolling by invitation

49 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloid Neuropathies, Familial

NCT05775224 2024-06-17

ASH Research Collaborative Data Hub

Enrolling by invitation

100,000 enrolled

Classical hematologyPlasma cell

Anemia, Sickle Cell, Multiple Myeloma, Neoplasms, Plasma Cell

NCT04210791 2024-02-26

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Enrolling by invitation

500 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Paraproteinemias

NCT03815279 2019-08-16

iStopMM

Phase 2 Enrolling by invitation

80 enrolled

Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Clinical Trials

LTFS

AI

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

AL-CA

ASH Research Collaborative Data Hub

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

iStopMM